Last reviewed · How we verify
Urinary Tract Irritation
Approved treatments
- (-)-Atropine · University of Kansas Medical Center
- secbutabarbital
- Urispas
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Urinary Tract Irritation patent landscape — cliff calendar, originator estates, attackable patents
- Urinary Tract Irritation treatment landscape brief
- Urinary Tract Irritation treatment updates RSS
Frequently asked questions about Urinary Tract Irritation
What drugs treat Urinary Tract Irritation?
Tracked treatments include (-)-Atropine, secbutabarbital, Urispas.
What is the treatment for Urinary Tract Irritation?
Standard treatment for Urinary Tract Irritation includes (-)-Atropine, secbutabarbital, Urispas. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Urinary Tract Irritation patent cliff · Urinary Tract Irritation CI report
- Treatment: (-)-Atropine · University of Kansas Medical Center
- Treatment: secbutabarbital
- Treatment: Urispas
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing